IT1247698B - 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti - Google Patents

1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Info

Publication number
IT1247698B
IT1247698B IT04808790A IT4808790A IT1247698B IT 1247698 B IT1247698 B IT 1247698B IT 04808790 A IT04808790 A IT 04808790A IT 4808790 A IT4808790 A IT 4808790A IT 1247698 B IT1247698 B IT 1247698B
Authority
IT
Italy
Prior art keywords
memory
pharmaceutical compositions
caprolattami
alchil
acylamine
Prior art date
Application number
IT04808790A
Other languages
English (en)
Other versions
IT9048087A1 (it
IT9048087A0 (it
Inventor
Fabio Giannessi
Orlando Ghirardi
Domenico Misiti
Maria Ornella Tinti
Roberto Cozzolino
Carlo Scolastico
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of IT9048087A0 publication Critical patent/IT9048087A0/it
Priority to IT04808790A priority Critical patent/IT1247698B/it
Priority to DK91830276.1T priority patent/DK0462949T3/da
Priority to DE69115135T priority patent/DE69115135T2/de
Priority to AT91830276T priority patent/ATE131159T1/de
Priority to EP91830276A priority patent/EP0462949B1/en
Priority to ES91830276T priority patent/ES2081463T3/es
Priority to JP3150301A priority patent/JPH04230266A/ja
Priority to US07/718,645 priority patent/US5155102A/en
Publication of IT9048087A1 publication Critical patent/IT9048087A1/it
Application granted granted Critical
Publication of IT1247698B publication Critical patent/IT1247698B/it
Priority to GR960400482T priority patent/GR3019076T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT04808790A 1990-06-21 1990-06-21 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti IT1247698B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT04808790A IT1247698B (it) 1990-06-21 1990-06-21 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
EP91830276A EP0462949B1 (en) 1990-06-21 1991-06-20 1-alkyl-3-(acylamino)-epsilon-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing same
DE69115135T DE69115135T2 (de) 1990-06-21 1991-06-20 1-Alkyl-3-(Acylamino)-Epsilon-Caprolactame zur Verbesserung der Lernfähigkeit und des Gedächtnisses und diese enthaltende pharmazeutische Zubereitungen.
AT91830276T ATE131159T1 (de) 1990-06-21 1991-06-20 1-alkyl-3-(acylamino)-epsilon-caprolactame zur verbesserung der lernfähigkeit und des gedächtnisses und diese enthaltende pharmazeutische zubereitungen.
DK91830276.1T DK0462949T3 (da) 1990-06-21 1991-06-20 3-(Acylamino- og 1-alkyl-3-(acylamino)-epsilon-caprolactamer til forøgelse af indlæring og hukommelse og farmaceutiske præparater indeholdende disse
ES91830276T ES2081463T3 (es) 1990-06-21 1991-06-20 1-alquil-3-(acilamino)-epsilon-caprolactamas como mejoradores del aprendimiento y memoria y composiciones farmaceuticas que las contienen.
JP3150301A JPH04230266A (ja) 1990-06-21 1991-06-21 学習および記憶力増進剤としての１−アルキル−３−（アシルアミノ）−ε−カプロラクタム類およびそれらを含む医薬組成物
US07/718,645 US5155102A (en) 1990-06-21 1991-06-21 1-alkyl-3-(acylamino)-ε-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing same
GR960400482T GR3019076T3 (en) 1990-06-21 1996-02-22 1-alkyl-3-(acylamino)-epsilon-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing same.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT04808790A IT1247698B (it) 1990-06-21 1990-06-21 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Publications (3)

Publication Number Publication Date
IT9048087A0 IT9048087A0 (it) 1990-06-21
IT9048087A1 IT9048087A1 (it) 1991-12-21
IT1247698B true IT1247698B (it) 1994-12-30

Family

ID=11264450

Family Applications (1)

Application Number Title Priority Date Filing Date
IT04808790A IT1247698B (it) 1990-06-21 1990-06-21 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Country Status (9)

Country Link
US (1) US5155102A (it)
EP (1) EP0462949B1 (it)
JP (1) JPH04230266A (it)
AT (1) ATE131159T1 (it)
DE (1) DE69115135T2 (it)
DK (1) DK0462949T3 (it)
ES (1) ES2081463T3 (it)
GR (1) GR3019076T3 (it)
IT (1) IT1247698B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1175405A4 (en) * 1999-02-09 2002-05-15 Bristol Myers Squibb Co LACTAM INHIBITORS OF FACTOR Xa AND ASSOCIATED METHOD
WO2000047207A1 (en) 1999-02-09 2000-08-17 Bristol-Myers Squibb Company LACTAM INHIBITORS OF FXa AND METHOD
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
JP5248779B2 (ja) * 2003-12-01 2013-07-31 ケンブリッジ エンタープライズ リミティド 抗炎症剤
CN101090885A (zh) * 2004-02-23 2007-12-19 塔夫茨大学信托人 作为构象限定的肽模拟物抑制剂的内酰胺类化合物
GB2418425B (en) * 2004-08-11 2008-09-03 Univ Cambridge Tech Anti-inflammatory agents
GB201009603D0 (en) 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti

Also Published As

Publication number Publication date
US5155102A (en) 1992-10-13
ATE131159T1 (de) 1995-12-15
DE69115135T2 (de) 1996-05-09
EP0462949A1 (en) 1991-12-27
IT9048087A1 (it) 1991-12-21
ES2081463T3 (es) 1996-03-16
JPH04230266A (ja) 1992-08-19
IT9048087A0 (it) 1990-06-21
EP0462949B1 (en) 1995-12-06
GR3019076T3 (en) 1996-05-31
DK0462949T3 (da) 1996-02-05
DE69115135D1 (de) 1996-01-18

Similar Documents

Publication Publication Date Title
TW226377B (it)
HU9401415D0 (en) Enzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives, pharmaceutical compositions contaning them, and process for producing them
ES2036926A1 (es) "procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
HU9400250D0 (en) Quinoline-or quinazoine derivatives process fop producing them and pharmaceutical compositions containing them
IT1247698B (it) 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
TW360650B (en) Pyridin-2-ylmethyloxy-pyridin-5-ylcarbamoyl-indoline derivatives, a process for the preparation thereof, and a pharmaceutical composition comprising them
IT1245870B (it) 3-acilammino-2-pirrolidinoni quali attivatori dei processi di appremdimento e della memoria e composizioni farmaceutiche comprendenti tali composti
IL83841A (en) 5-membered heterocyclic ring compounds substituted by phenyl and pyrrolidin-2-yl,their preparation and pharmaceutical compositions containing them
IT1231921B (it) 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
HUT55349A (en) Process for producing benzanilide derivatives and pharmaceutical compositions comprising same
IT1247697B (it) Composizioni farmaceutiche comprendenti 3-ammino-e-caprolattami per il potenziamento dei processi di apprendimento e della memoria.
ES463682A1 (es) Procedimiento de preparacion de nuevos derivados de la coen-zima b12.
DE3365933D1 (en) Substituted thienobenzodiazepinones, process for their preparation and medicines containing these compounds
HUT53093A (en) Process for producing substituted 3-amino-sidnonimine derivatives and pharmaceutical compositions them as active components
YU220483A (en) Process for obtaining gamma-butyrolactone derivatives
FI842639A (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.
MX9708021A (es) Fenilamidinas sustituidas, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
IT1247921B (it) Composti ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
GB1450793A (en) Pharmaceutical compositions containing dioxo-isoquinoline derivatives

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19940526